What is the price target for UPB stock?
12 analysts have analysed UPB and the average price target is 49.47 USD. This implies a price increase of 374.76% is expected in the next year compared to the current price of 10.42.
UPSTREAM BIO INC (UPB) Forecast, Price Target & Analyst Ratings
NASDAQ:UPB • US91678A1079
Current stock price
10.42 USD
+0.58 (+5.89%)
At close:
10.42 USD
0 (0%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UPSTREAM BIO INC (UPB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.77
- Revenue Estimate
- 446.42K
Price Target Details & History
Consensus Price Target and Range
Mean target
$49.47
Upside
+ 374.76%
From current price of $10.42 to mean target of $49.47, Based on 12 analyst forecasts
Low
$35.35
Median
$45.90
High
$78.75
Price Target Revisions
1 Month
0.00%
3 Months
1.04%
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for UPB. The average price target is 49.47 USD. This implies a price increase of 374.76% is expected in the next year compared to the current price of 10.42.
The average price target has been revised upward by 1.04% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
UPB was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about UPB.
In the previous month the buy percentage consensus was at a similar level.
UPB was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-27 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-12-18 | Mizuho | Initiate | Outperform |
| 2025-12-02 | LifeSci Capital | Initiate | Outperform |
| 2025-11-18 | Evercore ISI Group | Initiate | Outperform |
| 2025-10-14 | Truist Securities | Initiate | Buy |
| 2024-11-05 | TD Cowen | Initiate | Buy |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.77
- Revenue Estimate
- 446.42K
- Revenue Q2Q
- -21.13%
- EPS Q2Q
- -50.26%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-2.54%
Next Earnings Summary
UPB is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.77 USD and the consensus revenue estimate is 446.42K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.212M | 2.38M 96.37% | 2.37M -0.42% | 2.794M 17.89% | 1.507M -46.06% | 1.719M 14.07% | 5.729M 233.28% | 8.507M 48.49% | 92.697M 989.66% | 239.57M 158.44% | 463.61M 93.52% | 842.56M 81.74% | |
| EBITDA YoY % growth | -23.902M | -40.054M -67.58% | -77.675M -93.93% | -154.53M -98.94% | -183.82M -18.95% | -200.99M -9.34% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -23.909M | -40.114M -67.78% | -77.764M -93.86% | -158.196M -103.43% | -199.783M -26.29% | -216.822M -8.53% | -296.948M -36.95% | -260.872M 12.15% | -229.971M 11.85% | -114.72M 50.12% | 59.985M 152.29% | 368.83M 514.87% | |
| Operating Margin | -1,972.69% | -1,685.46% | -3,281.18% | -5,661.98% | -13,256.99% | -12,613.28% | -5,183.24% | -3,066.55% | -248.09% | -47.89% | 12.94% | 43.77% | |
| EPS YoY % growth | N/A | N/A | N/A | -2.60 67.12% | -3.18 -19.19% | -3.66 -15.23% | -5.25 -43.40% | -4.01 23.61% | -3.62 9.76% | -1.55 57.20% | 1.20 177.61% | 5.43 352.10% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.77 -50.26% | -0.76 -2.71% | -0.75 -19.44% | -0.81 -3.09% | -0.90 -17.30% | -0.95 -24.92% | -0.98 -30.87% | -1.06 -31.05% |
| Revenue Q2Q % growth | 446.42K -21.13% | 446.42K -52.36% | 448.44K -34.34% | 468.64K -29.84% | 747.4K 67.42% | 747.4K 67.42% | 757.5K 68.92% | 767.6K 63.79% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -45.196M -41.18% | -47.304M -6.67% | -49.262M -30.21% | -51.204M -20.04% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-25.35%
EPS Next 5 Year
-6.31%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
27.04%
Revenue Next 5 Year
101.45%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-36.38%
EBIT Next 5 Year
N/A
UPSTREAM BIO INC / UPB Forecast FAQ
What is the next earnings date for UPB stock?
UPSTREAM BIO INC (UPB) will report earnings on 2026-05-04.
What are the consensus estimates for UPSTREAM BIO INC (UPB) next earnings?
The consensus EPS estimate for the next earnings of UPSTREAM BIO INC (UPB) is -0.77 USD and the consensus revenue estimate is 446.42K USD.
What is the expected long term growth rate for UPSTREAM BIO INC (UPB)?
The expected long term growth rate for UPSTREAM BIO INC (UPB) is 27.04%.